Software as a Medical Device, or SaMD, is software intended to be used for one or more medical purposes without being part of a physical medical device. The term was defined by the International Medical Device Regulators Forum and is widely used by the FDA and European regulators. Examples include applications that analyse medical images, calculate drug dosing, or triage symptoms. In the EU, software that qualifies as a medical device is regulated under the MDR or IVDR and classified by the significance of the information it provides and the state of the patient. When such software uses artificial intelligence, the EU AI Act may also apply as a parallel regime. SaMD raises distinct regulatory questions around clinical evaluation, cybersecurity, change management for software updates, and post-market monitoring of real-world performance.
What is Software as a Medical Device?
Software as a Medical Device is software intended for a medical purpose that performs that purpose without being part of a hardware device.
Is all health software a medical device?
No. Software is only a medical device if it has a medical purpose as defined by the MDR or IVDR. General wellness and administrative software is generally out of scope.
Dėl vaistinių preparatų tiekimo sutrikimo
Informuojame, kad laikinai sutriko šių vaistinių preparatų tiekimas Lietuvos Respublikos rinkai. NPAKID7 Vaistinio preparato pavadinimas Veiklioji medžiaga Stiprumas Farmacinė forma Kiekis pakuotėje Registruoto...
Lithuania VVKTNewΑνάκληση της παρτίδας 202412 του Καλλυντικού προϊόντος ALOHA Nails & Cosmetics REPAIR GEL MILKY LILAC, λόγω παρουσίας TPO
Αρ. πρωτ. 92834 Ανάκληση της παρτίδας 202412 του Καλλυντικού προϊόντος ALOHA Nails & Cosmetics REPAIR GEL MILKY LILAC, λόγω παρουσίας
Greece EOFDėl vaistinių preparatų tiekimo sutrikimo
Informuojame, kad laikinai sutriko šių vaistinių preparatų tiekimas Lietuvos Respublikos rinkai. NPAKID7 Vaistinio preparato pavadinimas Veiklioji medžiaga Stiprumas Farmacinė forma Kiekis pakuotėje Registruoto...
Lithuania VVKTWinrevair (sotatercept) | Relatório de avaliação de financiamento público disponível | Deferimento
Data : 13/07/2026
Portugal INFARMEDMedicamentos e calor: Cuidados essenciais para garantir a sua segurança e eficácia
Data : 18/07/2026
Portugal INFARMEDAz NNGYK indikáción túli gyógyszerrendelési ajánlást adott ki a tranexamic acid hatóanyagú gyógyszerekre
Az NNGYK indikáción túli gyógyszerrendelési ajánlásai link: tranexamic acid hatóanyagú gyógyszerek lokális és intraarticularis alkalmazásának intézményi szintű engedélyezése vérzéscsökkentés céljából or
Hungary NNGYKWest Nil Virus (WNV) – FrankreichNeu
West Nil Virus (WNV) – Frankreich Neu Sicherheitsinformation | Blut & Gewebe | 17.07.2026 Dem Bundesamt für Sicherheit im Gesundheitswesen (BASG) wurde von der französischen Behörde mitgete...
Austria BASG